Phase 1/2 study of BLU-451, a central nervous system (CNS) penetrant, small molecule inhibitor of EGFR, in incurable advanced cancers with EGFR exon 20 insertion (ex20ins) mutations
Spira, Alexander I., Yu, Helena Alexandra, Sun, Lova, Nguyen, Danny, Pearson, Paul, Shim-Lopez, Jennifer, Hausman, Diana Felice, Le, Xiuning
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 1 study of ZW25, a bispecific anti-HER2 antibody, in patients with advanced HER2-expressing cancers
Hausman, Diana Felice, Hamilton, Erika Paige, Beeram, Muralidhar, Thimmarayappa, Jamuna, Ng, Gordon, Meric-Bernstam, Funda
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Phase 1 dose escalation of ZW25, a HER2-targeted bispecific antibody, in patients (pts) with HER2-expressing cancers
Meric-Bernstam, Funda, Beeram, Muralidhar, Blum, Mariela A., Hausman, Diana Felice, Infante, Jeffrey R., Patnaik, Amita, Piha-Paul, Sarina Anne, Rasco, Drew W., Rowse, Gerry, Thimmarayappa, Jamuna, Tolcher, Anthony W., Hamilton, Erika Paige
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Single agent activity of ZW25, a HER2-targeted bispecific antibody, in heavily pretreated HER2-expressing cancers
Meric-Bernstam, Funda, Beeram, Murali, Mayordomo, Jose Ignacio, Hanna, Diana L., Ajani, Jaffer A., Blum Murphy, Mariela A., Murthy, Rashmi Krishna, Piha-Paul, Sarina Anne, Bauer, Todd Michael, Bendell, Johanna C., El-Khoueiry, Anthony B., Lenz, Heinz-Josef, Press, Michael F., Royer, Nels, Hausman, Diana Felice, Hamilton, Erika Paige
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
IND 205B: A phase II study of the PI3K inhibitor PX-866 and continued abiraterone/prednisone in patients with recurrent or metastatic castration resistant prostate cancer (CRPC) with PSA progression on abiraterone/prednisone
Hotte, Sebastien J., Joshua, Anthony M., Torri, Vamsee, Macfarlane, Robyn Jane, Basappa, Naveen S., Powers, Jean, Winquist, Eric, Mukherjee, Som, Gregg, Richard William, Kollmannsberger, Christian K., Finch, Daygen L., Xu, Hao, Hausman, Diana Felice, Seymour, Lesley, Eisenhauer, Elizabeth A., Chi, Kim N.
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
PX-866 and docetaxel in patients with advanced solid tumors
Jimeno, Antonio, Senzer, Neil N., Rudin, Charles M., Ma, Wen Wee, Halmos, Balazs, Schnadig, Ian D., Levy, Benjamin, Hausman, Diana Felice, Peterson, Scott, Walker, Luke N.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase II study of PX-866 in recurrent glioblastoma
Pitz, Marshall W., Eisenhauer, Elizabeth A., MacNeil, Mary Valeria, Thiessen, Brian, Macdonald, David R., Easaw, Jacob C., Eisenstat, David Daniel, Kakumanu, Ankineedu Saranya, Squire, Jeremy, Tsao, Ming Sound, Kamel-Reid, Suzanne, Tassignon, Aurelie, Hausman, Diana Felice, Mason, Warren P.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article